Durability of SARS-CoV-2–Specific T-Cell Responses at 12 Months PostinfectionZhongyan Lu, Daniel E. Clark, Christopher C. Broder et al.|The Journal of Infectious Diseases|2021Cited by 42
Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) Instrument in Patients With Coronavirus Disease 2019Stephanie A Richard, M. Wayman, Nusrat J Epsi et al.|Open Forum Infectious Diseases|2021Cited by 36
A machine learning approach identifies distinct early-symptom cluster phenotypes which correlate with hospitalization, failure to return to activities, and prolonged COVID-19 symptomsNusrat J Epsi, John H. Powers, David A Lindholm et al.|PLoS ONE|2023Cited by 21
Precision Symptom Phenotyping Identifies Early Clinical and Proteomic Predictors of Distinct COVID-19 SequelaeNusrat J Epsi, Stephanie A Richard, Josh Chenoweth et al.|The Journal of Infectious Diseases|2024Cited by 18
Patterns of restricted TCR usage following SARS-CoV-2 vaccination and severe diseaseEmily Parsons, Zhongyan Lu, Stephanie A Richard et al.|Frontiers in Immunology|2025Cited by 1